COVID-19 Pandemic Led to Delays in Medical Care

Publication
Article
Oncology Nursing NewsApril 2021
Volume 15
Issue 02

More than one-third of adults report delaying or forgoing health care either because of fear of infection or their physicians offering limited services.

Astudy by the Urban Institute, a nonprofit health policy center, found that more than one-third of adults between the ages of 18 and 64 have forgone or delayed medical care because of the coronavirus disease 2019 (COVID-19) pandemic.1 According to the report, as of September 2020, 36% of adults reported delaying or forgoing health care because they were worried about becoming infected with COVID-19 or because their providers offered limited services because of the pandemic.

Among respondents with 1 or more chronic condition, 40.7% reported they have delayed or forgone care, whereas 56.3% of respondents with both a physical and a mental health condition have done the same, the report says. Black adults were more likely (39.7%) to report forgoing or delaying care than Hispanic/Latinx (35.5%) or White (34.3%) adults and more likely to report forgoing or delaying multiple types of care, at 28.5% compared with 22.3% and 21.1% respectively, according to the report.

The most common type of medical care delayed or forgone was dental at 25.3%, followed by visiting a primary care physician or specialist at 20.6%, and receiving preventive health screenings or medical tests at 15.5%, the report says.

Respondents with 1 or more chronic health conditions such as cancer, hypertension, diabetes, respiratory illness, heart disease, kidney disease, and mental health disorders made up the majority (76%) of those who have delayed or forgone health care. Delaying and forgoing care is not without its dangers; 32.6% of respondents say that doing so has worsened 1 or more of their health conditions or limited their ability to work or do other daily activities, according to the report.

Related Videos
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
© 2024 MJH Life Sciences

All rights reserved.